Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieke H J Simkens

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Patient Education and Counseling|March 11, 2019
Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancerLotte Keikes, Judith de Vos-Geelen, Jan Willem B de Groot, et al.
Cancer Medicine|December 19, 2019
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trialSophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
Lancet (London, England)|April 12, 2015
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer GroupLieke H J Simkens, Harm van Tinteren, Anne May, et al.
British Journal of Cancer|October 13, 2020
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy eraG Emerens Wensink, Marloes A G Elferink, Anne M May, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Patient Education and Counseling|March 11, 2019
Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancerLotte Keikes, Judith de Vos-Geelen, Jan Willem B de Groot, et al.
Cancer Medicine|December 19, 2019
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trialSophie A Kurk, Petra H M Peeters, Bram Dorresteijn, et al.
Lancet (London, England)|April 12, 2015
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer GroupLieke H J Simkens, Harm van Tinteren, Anne May, et al.
British Journal of Cancer|October 13, 2020
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy eraG Emerens Wensink, Marloes A G Elferink, Anne M May, et al.
Pageof 2